CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studies.
about
Impact of illicit opioid use on T cell subsets among HIV-infected adults.Accelerated disease progression and robust innate host response in aged SIVmac239-infected Chinese rhesus macaques is associated with enhanced immunosenescence.Is HIV a model of accelerated or accentuated aging?Changes in PINCH levels in the CSF of HIV+ individuals correlate with hpTau and CD4 count.Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection.Immune activation and HIV persistence: implications for curative approaches to HIV infection.Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis.Sex, age, race and intervention type in clinical studies of HIV cure: a systematic review.CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART.CD28 family of receptors on T cells in chronic HBV infection: Expression characteristics, clinical significance and correlations with PD-1 blockade.Older HIV-infected patients on antiretroviral therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reduction.First-line cART regimen impacts the course of CD8+ T-cell counts in HIV-infected patients that achieve sustained undetectable viral load.Use of first-generation HCV protease inhibitors in patients coinfected by HIV and HCV genotype 1.Terminal differentiation of T cells is strongly associated with CMV infection and increased in HIV-positive individuals on ART and lifestyle matched controls.Intracellular HIV-1 RNA and CD4+ T-cell activation in patients starting antiretrovirals.Changes in Markers of T-Cell Senescence and Exhaustion With Atazanavir-, Raltegravir-, and Darunavir-Based Initial Antiviral Therapy: ACTG 5260s.CD4⁺CD28null T lymphocytes resemble CD8⁺CD28null T lymphocytes in their responses to IL-15 and IL-21 in HIV-infected patients.Cross-sectional study of CD4: CD8 ratio recovery in young adults with perinatally acquired HIV-1 infection.
P2860
Q33637866-309F43AD-F046-49B0-8EFF-A5B4242D4E59Q33671468-EB422684-CB10-4894-AD09-BA6CE8BA91F1Q33792651-9C14C7CC-5EAB-4C47-AFFD-935B31592C8DQ33924678-EE707EA2-DADA-46A3-92FD-7EA6BA49AB12Q33947817-FE83F3FF-F158-4991-997E-03A4CF30839DQ34351320-E632FB49-1D0F-4669-BF30-557F480BBB3EQ34412603-002C0D3D-2A0D-46EE-A768-6E4615ADE9CBQ34870233-256B6926-4ABB-4E3C-BD91-D2FC00CFB899Q36185688-F147DBBF-0BAD-459B-8991-5A72072B3B8FQ37083009-0C87B667-9379-4012-AF97-54CE3A81C2C8Q37247131-B6F9055A-7169-4792-80DD-1FC4A4D83C7EQ37354804-5B351EB8-AE4C-4F5E-B327-33F21CD5175BQ38153794-73003A07-B92A-4FF6-8108-DA26D44E8B09Q40094624-A629F412-251C-49FC-9FEF-E99D3FE7B5EFQ40266878-3463C44D-66FA-4281-B77C-60C3988E6837Q40632652-1399768E-1722-458C-94C6-65C7481F9547Q41190637-2E295A6D-9B3D-408C-BBF1-06C068C70BDFQ49712180-E1E80138-6081-4609-B846-B009510F347E
P2860
CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studies.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
CD28-negative CD4+ and CD8+ T ...... clinical trials group studies.
@ast
CD28-negative CD4+ and CD8+ T ...... clinical trials group studies.
@en
type
label
CD28-negative CD4+ and CD8+ T ...... clinical trials group studies.
@ast
CD28-negative CD4+ and CD8+ T ...... clinical trials group studies.
@en
prefLabel
CD28-negative CD4+ and CD8+ T ...... clinical trials group studies.
@ast
CD28-negative CD4+ and CD8+ T ...... clinical trials group studies.
@en
P2093
P2860
P356
P1476
CD28-negative CD4+ and CD8+ T ...... clinical trials group studies.
@en
P2093
Alan Landay
Ann C Collier
Cara Wilson
Dorothy E Lewis
Elizabeth Connick
Katherine Tassiopoulos
Peter Hunt
Ronald Bosch
P2860
P304
P356
10.1093/INFDIS/JIS260
P407
P577
2012-03-23T00:00:00Z